Development and Retrospective Application of Novel Outcome Measure: Sturge–Weber Syndrome Acute Crisis (SWAC) Index
Annals of the Child Neurology Society · 2026-06 · 4 (2) · 132-139
DOI: 10.1002/cns3.70059 ↗Kurz gefasst
Fachartikel in der Zeitschrift Annals of the Child Neurology Society, online erschienen am 24.03.2026. Verfasst von Kieran D McKenney und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology and Developmental Medicine Hugo Moser Kennedy Krieger Research Institute Baltimore Maryland USA. Die Arbeit nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NICHD NIH HHS.
Abstract (Originalsprache)
Objective
Sturge–Weber syndrome (SWS) symptoms frequently overlap in neurological acute crises (ACs) presenting with seizures, stroke‐like episodes (SLE), and headaches. Recent efforts to develop a prospective drug trial highlighted the need for a new outcome measure capable of quantifying these symptoms during an SWS AC. We aimed to develop such a measure and evaluate its practical application.
Methods
The Sturge Weber Acute Crisis (SWAC) index was developed based on clinical care guidelines and experience. We retrospectively applied the SWAC to an open‐label prospective drug trial published in 2020; SWAC scores were assigned for every AC during 6‐month baseline and treatment phase periods.
Results
Six of 10 subjects experienced 670 ACs; only 78/670 ACs were included in the primary quantitative analyses (one subject was an extreme outlier) and 71/78 events were single‐symptom while 7/78 included multiple symptoms. Three of six subjects experienced improved median seizure total score; all three improved their median SLE total score. Three of five subjects with headache improved their median headache total score. Poisson‐log GLMM models demonstrated significant improvements in composite severity and total, SLE duration and total, and headache severity and total index scores.
Interpretation
The newly developed SWAC index, applied retrospectively, reflected site‐PI clinical experience, quantified the severity and duration of SWS ACs ranging from mild to severe, and better enabled comparison of treatment versus baseline responses. These results support additional studies with the SWAC index to further assess clinical utility and use in future treatment trials in SWS.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Neurology and Developmental Medicine Hugo Moser Kennedy Krieger Research Institute Baltimore Maryland USA.
- Department of Quality, Patient Safety, and Professional Affairs Kennedy Krieger Institute Baltimore Maryland USA.
- Department of Mental Health Johns Hopkins Bloomberg School of Public Health Baltimore Maryland USA.
- Department of Pediatrics University of Cincinnati College of Medicine Cincinnati Ohio USA.
- Division of Hematology, Cincinnati Children's Hospital Medical Center Cincinnati Ohio USA.
- Department of Pediatrics Johns Hopkins School of Medicine Baltimore Maryland USA.
ORCID-Profile: Kieran D McKenney, Adrienne M Hammill
Förderung
- NICHD NIH HHS
Zitieren
APA
McKenney, K. D., Kalb, L. G., Hammill, A. M., & Comi, A. M. (2026). Development and Retrospective Application of Novel Outcome Measure: Sturge–Weber Syndrome Acute Crisis (SWAC) Index. Annals of the Child Neurology Society, 4(2), 132-139. https://doi.org/10.1002/cns3.70059
Vancouver
McKenney KD, Kalb LG, Hammill AM, Comi AM. Development and Retrospective Application of Novel Outcome Measure: Sturge–Weber Syndrome Acute Crisis (SWAC) Index. Annals of the Child Neurology Society. 2026;4(2):132-139. doi:10.1002/cns3.70059
BibTeX
@article{McKenney2026,
author = {McKenney, Kieran D and Kalb, Luther G and Hammill, Adrienne M and Comi, Anne M},
title = {Development and Retrospective Application of Novel Outcome Measure: Sturge–Weber Syndrome Acute Crisis (SWAC) Index},
journal = {Annals of the Child Neurology Society},
year = {2026},
volume = {4},
number = {2},
pages = {132--139},
doi = {10.1002/cns3.70059}
}
EUVIMED